Effects of Taping & Exercise Therapy on Lower Back Musculoskeletal Conditions in Pakistani Patients

NCT ID: NCT05649774

Last Updated: 2023-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-14

Study Completion Date

2023-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lower back pain has been one of the most frequently occurring musculoskeletal disorder among the females. This act as a global burden and is highly prevalent in our society. This pain can result in life long disability, loss of function and mobility among individuals. The female of the society suffers from lower back pain the most because of the under lying causes, prolong standing and stooping as well as because of hormonal changes in their bodies

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After studying the prevalence of the lower back pain among the females of Pakistan, the investogator find the need to assess the type of their pain and find out the best way to ease their pains. The motive was to develop a treatment protocol whose effects last longer and is inexpensive for the management of lower back pain.

Moreover, the investigator decided to study that which treatment protocol is better when compared to another and what is the role of sham treatment when given to the patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Back Pain Musculoskeletal Diseases or Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study was a parallel group, four arm superiority trial with 1:1 allocation ratio and balanced randomization
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Myofascial Release (MFR)

The therapist will place its hands on the T12-L1 levels as well as on the sacrum. A cross handed hold will be performed along the fascia. Then for the gluteus Medius and maximus muscle, the therapist will stand facing the participant's leg and closed to the superior border of participant's pelvis. The therapist will place the palm of the hand on the anterior surface, allowing the fingers to rest on the outer fibers of the gluteal muscles stabilizing the pelvis of the participants. Allow the participant to flex its knee while applying adequate amount of stretch on the hip joint in an open pack position. Hold, wait for the release and stretch again. for tensor fascia Latae, The therapist will place several slightly adducted fingers of its one hand on the superior fibers proximal to the insertion on the anterior superior iliac crest and the thumb as well as the other fingers of the other hand on the distal muscle fibers. Hold, wait for the release and stretch again.

Group Type ACTIVE_COMPARATOR

Therapy

Intervention Type PROCEDURE

Only Myofascial Release will be provided

Kinesio Taping (KT)

Lumbar star correction technique was applied. 4 tape I strips will be cut. The paper from the center will be torn. The targeted area will be stretched as tolerated at the lumbar region. The therapist will apply 25% to 35% tension to the strip within the therapeutic zone over the target tissue. End the strip with no tension and activate the adhesive. For the second strip change the posture in order to change the stretch on the tissue, apply the second strip with 25% to 35% tension in the center of the tape and end with no tension. Activate the adhesive. Now flex the trunk and rotate on one side. Apply the third tape strip with 25% to 35% tension in the center of the tape. Apply the fourth tape strip with flexion and rotation on the opposite side again with 25% to 35% tension on the strip.

The tape will be changed 3 times per week.

Group Type ACTIVE_COMPARATOR

Taping technique

Intervention Type PROCEDURE

Only Kinesiotaping will be provided

Myofascial Release with Taping (MFKT)

Same Protocol of MFR followed by KT

Group Type EXPERIMENTAL

Therapy with taping

Intervention Type PROCEDURE

Myofascial release will be provided followed by Kinesiotaping

Placebo Treatment

The control group received a sham myofascial release for 40 minutes per treatment session, three times a week for three weeks. The sham myofascial release was applied by gently placing the hands over the same areas treated in the MFR group,without sliding, just enough to maintain contact for the desired time.

Group Type SHAM_COMPARATOR

SHAM

Intervention Type PROCEDURE

Placebo Treatment will be given

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapy

Only Myofascial Release will be provided

Intervention Type PROCEDURE

Taping technique

Only Kinesiotaping will be provided

Intervention Type PROCEDURE

Therapy with taping

Myofascial release will be provided followed by Kinesiotaping

Intervention Type PROCEDURE

SHAM

Placebo Treatment will be given

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Myofascial Release Taping Therapy followed by taping

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Females who were willing to participate.
* Participants with nonspecific lower back pain will only be included and screened through the screening questionnaire.

Exclusion Criteria

* Post-menopausal women
* Females with any diagnosed co-morbidity.
* Back pain progressive to any neurological deficit
* Sustained or increased back pain with loss of appetite and unexplained weight loss accompanied with fever, nausea and chills
* With any known spinal or lower back pathology
* Tumor of the spine
* Any underlying diseases of spinal cord (i.e, ankylosing spondylosis, spondolisthesis)
* With any steroid therapy for lower back pain in the past three months
* Any inflammatory rheumatic disease
* Sensitive skin or any skin allergy or dermatological condition
* Any rehabilitative services taken for the lower back pain in the past two months
* Rejection to manual conatct
Minimum Eligible Age

28 Years

Maximum Eligible Age

38 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Karachi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kiran Arshad

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kiran Arshad, M.Phil

Role: PRINCIPAL_INVESTIGATOR

University of Karachi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al-Tibri Medical college and hospital

Karachi, Sindh, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KArshad

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.